Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cabazitaxel.

Literature DB >> 20811375

Cabazitaxel.

Matthew D Galsky¹, Argyris Dritselis, Peter Kirkpatrick, William K Oh.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 20811375 DOI： 10.1038/nrd3254

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

× No keyword cloud information.

13 in total

Review 1. Microtubules as a target for anticancer drugs.

Authors: Mary Ann Jordan; Leslie Wilson
Journal: Nat Rev Cancer Date: 2004-04 Impact factor: 60.716

2. Sipuleucel-T.

Authors: Celestia S Higano; Eric J Small; Paul Schellhammer; Uma Yasothan; Steven Gubernick; Peter Kirkpatrick; Philip W Kantoff
Journal: Nat Rev Drug Discov Date: 2010-07 Impact factor: 84.694

3. Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer.

Authors: Daniel C Danila; Michael J Morris; Johann S de Bono; Charles J Ryan; Samuel R Denmeade; Matthew R Smith; Mary-Ellen Taplin; Glenn J Bubley; Thian Kheoh; Christopher Haqq; Arturo Molina; Aseem Anand; Michael Koscuiszka; Steve M Larson; Lawrence H Schwartz; Martin Fleisher; Howard I Scher
Journal: J Clin Oncol Date: 2010-02-16 Impact factor: 44.544

4. Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate.

Authors: Alison H M Reid; Gerhardt Attard; Daniel C Danila; Nikhil Babu Oommen; David Olmos; Peter C Fong; L Rhoda Molife; Joanne Hunt; Christina Messiou; Christopher Parker; David Dearnaley; Joost F Swennenhuis; Leon W M M Terstappen; Gloria Lee; Thian Kheoh; Arturo Molina; Charles J Ryan; Eric Small; Howard I Scher; Johann S de Bono
Journal: J Clin Oncol Date: 2010-02-16 Impact factor: 44.544

5. Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.

Authors: Alain C Mita; Louis J Denis; Eric K Rowinsky; Johann S Debono; Andrew D Goetz; Leonel Ochoa; Bahram Forouzesh; Muralidhar Beeram; Amita Patnaik; Kathleen Molpus; Dorothée Semiond; Michèle Besenval; Anthony W Tolcher
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531

6. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

Authors: Jennifer A Locke; Emma S Guns; Amy A Lubik; Hans H Adomat; Stephen C Hendy; Catherine A Wood; Susan L Ettinger; Martin E Gleave; Colleen C Nelson
Journal: Cancer Res Date: 2008-08-01 Impact factor: 12.701

7. Development of a second-generation antiandrogen for treatment of advanced prostate cancer.

Authors: Chris Tran; Samedy Ouk; Nicola J Clegg; Yu Chen; Philip A Watson; Vivek Arora; John Wongvipat; Peter M Smith-Jones; Dongwon Yoo; Andrew Kwon; Teresa Wasielewska; Derek Welsbie; Charlie Degui Chen; Celestia S Higano; Tomasz M Beer; David T Hung; Howard I Scher; Michael E Jung; Charles L Sawyers
Journal: Science Date: 2009-04-09 Impact factor: 47.728

8. A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients.

Authors: X Pivot; P Koralewski; J L Hidalgo; A Chan; A Gonçalves; G Schwartsmann; S Assadourian; J P Lotz
Journal: Ann Oncol Date: 2008-04-23 Impact factor: 32.976

9. Cancer statistics, 2009.

Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal: CA Cancer J Clin Date: 2009-05-27 Impact factor: 508.702

10. Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer.

Authors: Brian Schurko; William K Oh
Journal: Nat Clin Pract Oncol Date: 2008-07-22

47 in total

1. Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.

Authors: Enrique Calvo; Isabel Barasoain; Ruth Matesanz; Benet Pera; Emilio Camafeita; Oriol Pineda; Ernest Hamel; Christopher D Vanderwal; José Manuel Andreu; Juan A López; José Fernando Díaz
Journal: Biochemistry Date: 2011-12-30 Impact factor: 3.162

2. Design and synthesis of simplified taxol analogs based on the T-Taxol bioactive conformation.

Authors: Jielu Zhao; Susan Bane; James P Snyder; Haipeng Hu; Kamalika Mukherjee; Carla Slebodnick; David G I Kingston
Journal: Bioorg Med Chem Date: 2011-10-13 Impact factor: 3.641

3. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.

Authors: Zhijian He; Anita Schulz; Xiaomeng Wan; Joshua Seitz; Herdis Bludau; Daria Y Alakhova; David B Darr; Charles M Perou; Rainer Jordan; Iwao Ojima; Alexander V Kabanov; Robert Luxenhofer
Journal: J Control Release Date: 2015-02-26 Impact factor: 9.776

Review 4. Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.

Authors: Joana Caiado; Matthieu Picard
Journal: Curr Allergy Asthma Rep Date: 2014-08 Impact factor: 4.806